Skip to main content
Log in

Reactive metabolites and adverse drug reactions

Clinical considerations

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Idiosycratic reactions can affect many different organ systems, either as-an isolated event (e.g., hepatitis) or as part of a syndrome (e.g., drug hypersensitivity syndrome). Formation of reactive metabolites of drugs in conjunction with a decreased ability for detoxification is believed to be the initiating step in many idiosyncreatic reactions.

The drug hypersensitivity syndrome, defined by the presence of fever, rash and internal organ involvement, is estimated to occur in approx 1 in 1000 to 1 in 10,000 exposures with drugs such as anticonvulsants sulfonamide antibiotics, allopurinol and dapsone. Symptoms usually start within 2–8 wk of drug initiations. Serum sicknesslikes reaction, most frequently found after 7–14 d of drug exposure, is distinguished by a fever, cutaneous eruption and arthralgias. Medications such as cefaclor, minocycline and bupropions are most frequently implicated in this reaction. In contrast, drug-induced lupus can occur 1–2 yr after initiation of medication. Drug-induced lupus is characterized by musculoskeletal complaints and fever and weight loss. Drugs most commonly associated with drug-induced lupus include procainamide, hydralazine, chlorpromazine, isoniazid, and minocycline.

Management of patients who develop idiosyncratic reactions includes discontinuation of the implicated drug, initiation of corticosteroids (when appropriate), and symptomatic relief as required. Internal organ involvement, which may initially be asymptomatic, should be monitored. Confirmatory or diagnostic tests are not readily available in most areas, except for research purposes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Knowles, S., Uetrecht, J., and Shear, N. (2000), Lancet. 356, 1587–1591.

    Article  PubMed  CAS  Google Scholar 

  2. Shear, N. and Spielberg, S. (1988), J. Clin. Investig. 82, 1826–1832.

    Article  PubMed  CAS  Google Scholar 

  3. Roujeau, J. C. and Stern, R. (1994), N. Engl. J. Med. 331(19), 1272–1285.

    Article  PubMed  CAS  Google Scholar 

  4. Gupta, A., Eggo, M., Uetrecht J., et al. (1992), Clin. Pharmacol. Ther. 51, 56–67.

    Article  PubMed  CAS  Google Scholar 

  5. Knowles, S., Shapiro, L., and Shear, N. (1996), Arch. Dermatol. 132, 934–939.

    Article  PubMed  CAS  Google Scholar 

  6. Lawley, T., Bielory, L., Gascon, P., Yancey, K., Young, N., and Frank, M., (1984), N. Engl. J. Med. 311, 1407–1413.

    Article  PubMed  CAS  Google Scholar 

  7. Heckbert, S., Stryker, W., Coltin, K., Manson, J., and Platt, R. (1990), Am. J. Epidemiol. 132, 336–342.

    PubMed  CAS  Google Scholar 

  8. Stricker, B. and Tijssen, J. (1992), J. Clin. Epidemiol. 45, 1177–1184.

    Article  PubMed  CAS  Google Scholar 

  9. Kearns, G., Wheeler, J., Childress, S., and Letzig, L. (1994), J. Pediatr. 125, 805–811.

    Article  PubMed  CAS  Google Scholar 

  10. McCollom, R., Elbe, D., and Ritchie, A. (2000) Ann. Pharmacother. 34, 471–473.

    Article  PubMed  CAS  Google Scholar 

  11. Hess, E. (1988), N. Engl. J. Med. 318, 1460–1462.

    Article  PubMed  CAS  Google Scholar 

  12. Gioud, M., Kaci, M., and Monier, J. (1982), Arthritis Rheum. 25, 407–413.

    Article  PubMed  CAS  Google Scholar 

  13. Yung, R. and Richardson, B. (1994), Rheum. Dis. Clin. N. Am. 20, 61–86.

    CAS  Google Scholar 

  14. Akin, E., Miller, L., and Tucker, L. (1997), Pediatrics 926–928.

  15. Gaffney, K. and Merry, P. (1996), Br. J. Rheumatol. 35, 1326–1336.

    Article  Google Scholar 

  16. Gough, A., Chapman, S., Wagstaff, K., Emery, P., and Elias, E. (1996), Br. Med. J. 312, 169–172.

    CAS  Google Scholar 

  17. Perry, H., Tan, E., Carmody, S., and Sakamoto, A. (1970), J. Lab. Clin. Med. 76, 114–125.

    PubMed  Google Scholar 

  18. Rieder, M., Shear, N., Kanee, A., Tan, B., and Spielberg, S. (1991), Clin. Pharmacol. Ther. 49, 13–17.

    Article  PubMed  CAS  Google Scholar 

  19. Wolkenstein, P., Laurent, P., Revuz, J., Roujeau, J., and Bagot, M. (1995), Arch. Dermatol. 131, 544–551.

    Article  PubMed  CAS  Google Scholar 

  20. Batchelor, J., Welsh, K., Tinoco, R., et al. (1980), Lancet 1, 1107–1109.

    Article  PubMed  CAS  Google Scholar 

  21. Dunphy, Oliver, M., Rands, A., et al. (2000), Br. J. Dermatol. 142, 461–467.

    Article  PubMed  CAS  Google Scholar 

  22. Uetrecht, J. (2000), Curr. Drug Metab. (2000), 1, 133–141.

  23. Park, B., Naisbitt, D., Gordon, S., et al. (2001), Toxicology 158, 11–23.

    Article  PubMed  CAS  Google Scholar 

  24. Uetrecht, J. (1992), Drug Metab. Rev. 24, 299–366.

    Article  PubMed  CAS  Google Scholar 

  25. Pirmohamed M., Kitteringham, N., and Park, B. (1994), Drug Saf. 11, 114–144.

    PubMed  CAS  Google Scholar 

  26. Uetrecht, J. (1999), Chem. Res. Toxicol. 12, 387–395.

    Article  PubMed  CAS  Google Scholar 

  27. Kenna, J. and Neuberger, J. (1995), Clin. Immunother. 3, 108–124.

    Google Scholar 

  28. Spielberg, S., Gordon, G., Blake, D., Mellits, D., and Bross, D. (1981), J. Pharmacol. Exp. Ther. 217, 386–389.

    PubMed  CAS  Google Scholar 

  29. Gaedigk, A., Speilberg, S., and Grant, D. (1994), Pharmacogenetics 4, 142–153.

    Article  PubMed  CAS  Google Scholar 

  30. Green, V., Primohamed, M., and Kitteringham, N., et al. (1995), Biochem. Pharmacol. 50, 1353–1359.

    Article  PubMed  CAS  Google Scholar 

  31. Parman, T., Chen, G., and Wells, P. (1998), J. Biol. Chem. 273, 25,079–25,088.

    Article  CAS  Google Scholar 

  32. Munns, A., De Voss, J., Hooper, W., Dickinson, R., and Gillam, E. (1997), Chem. Res. Toxicol. 10, 1049–1058.

    Article  PubMed  CAS  Google Scholar 

  33. Ju, C. and Uetrecht, J. (1999), J. Pharmacol. Exp. Ther. 288, 51–56.

    PubMed  CAS  Google Scholar 

  34. Leeder, J., Riley, R., Cook, V., and Spielberg, S. (1992), J. Pharmacol. Exp. Therap. 263, 360–367.

    CAS  Google Scholar 

  35. Sullivan, J. and Shear, N. (2001), Arch. Dermatol. 137, 357–364.

    PubMed  CAS  Google Scholar 

  36. Rambeck, B., and Wolf, P. (1993), Clins. Pharmacokinet. 25, 433–443.

    CAS  Google Scholar 

  37. Cribb, A. and Spielberg, S. (1992), Clin. Pharmacol. Ther. 51, 522–526.

    Article  PubMed  CAS  Google Scholar 

  38. Cribb, A., Spielberg, S., and Griffen, G. (1995), Drug Metab. Dispos. 23, 406–414.

    PubMed  CAS  Google Scholar 

  39. Rieder, M., Mask, M., and Bird, I. (1992), Can. J. Physiol. Pharmacol. 70, 719–722.

    PubMed  CAS  Google Scholar 

  40. Rieder, M., Sisson, F., and Bird, J. (1992), Intl. J. Immunopharmacol. 14, 1175–1180.

    Article  CAS  Google Scholar 

  41. Naibitt, D. Hough, S., Gill, H., Pirmohamed, M., Kitteringham, N., and Park, B. (1999), Br. J. Pharmacol. 12, 1393–1407.

    Article  Google Scholar 

  42. Cribb, A., Pohl, L., Spielberg, S., and Leeder, J. (1997), J. Pharmacol. Exp. Ther. 282, 1064–1071.

    PubMed  CAS  Google Scholar 

  43. Barone, C., Bianchi, M., Lee, B., and Mitra, A. (1993), J. Oral Maxillofac. Surg. 51, 264–268.

    Article  PubMed  CAS  Google Scholar 

  44. Prendville, J., Hebert, A., Greenwald, M., and Esterly, N. (1989), J. Pediatr. 115, 881–887.

    Article  Google Scholar 

  45. Wolkenstein, P., Latarjet, J., Roujeau, J. et al. (1998), Lancet 352, 1586–1589.

    Article  PubMed  CAS  Google Scholar 

  46. Viard, I., Wehrli, P., Bullani, R., et al. (1998), Science 282, 490–493.

    Article  PubMed  CAS  Google Scholar 

  47. Neuman, M., Malkiewicz I., and Shear, N. (2000), Clin. Biochem. 33, 517–524.

    Article  PubMed  CAS  Google Scholar 

  48. Nyfeler, B. and Pichler, W. (1997), Clin. Exp. Allergy 27, 175–181.

    Article  PubMed  CAS  Google Scholar 

  49. Knowles, S., Shapiro, L., and Shear, N. (1999), Drug Saf. 21, 489–501.

    Article  PubMed  CAS  Google Scholar 

  50. Alldredge, B., Knutsen, A., and Ferriero, D. (1994), Pediatr. Neurol. 10, 169–171.

    Article  PubMed  CAS  Google Scholar 

  51. Zakrzewska, J. and Ivanyi, L. (1988), J. Allergy Clin. Immunol. 82, 110–115.

    Article  PubMed  CAS  Google Scholar 

  52. Pirmohamed, M., Graham, A., Roberts, P., Smith, D., Chadwick, D., Breckenridge, A., and Park, B. (1991), Br. J. Clin. Pharmacol. 32, 741–749.

    PubMed  CAS  Google Scholar 

  53. Knowles, S., Shapiro, L., and Shear, N. (2001), Drug Saf. 24, 239–247.

    Article  PubMed  CAS  Google Scholar 

  54. Vial, T., Pont, J., Pham, E., Rabilloud, M., and Desotes, J. (1992), Ann. Pharmacother. 26, 910–914.

    PubMed  CAS  Google Scholar 

  55. Grammer, L. (1996), JAMA 275, 1152–1153.

    Article  PubMed  CAS  Google Scholar 

  56. Shapiro, L., Knowles, S., and Shear, N. (1997), Arch. Dermatol. 133, 1224–1230.

    Article  PubMed  CAS  Google Scholar 

  57. Gennis, M., Vemuri, R., Burns, E., Hill, J., Miller, M., and Spielberg, S. (1991), Am. J. Med. 91, 631–634.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neil H. Shear.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knowles, S.R., Shapiro, L.E. & Shear, N.H. Reactive metabolites and adverse drug reactions. Clinic Rev Allerg Immunol 24, 229–238 (2003). https://doi.org/10.1385/CRIAI:24:3:229

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CRIAI:24:3:229

Index Entries

Navigation